Produktbild: Targeting Chronic Inflammatory Lung Diseases Using Advanced Drug Delivery Systems
- 23%

Targeting Chronic Inflammatory Lung Diseases Using Advanced Drug Delivery Systems

23% sparen

151,99 € UVP 198,50 €

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

07.08.2020

Herausgeber

Kamal Dua + weitere

Verlag

Elsevier Science & Technology

Maße (B/H)

19/23,4 cm

Gewicht

1250 g

Sprache

Englisch

ISBN

978-0-12-820658-4

Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

07.08.2020

Herausgeber

Verlag

Elsevier Science & Technology

Maße (B/H)

19/23,4 cm

Gewicht

1250 g

Sprache

Englisch

ISBN

978-0-12-820658-4

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

Die Leseprobe wird geladen.
  • Produktbild: Targeting Chronic Inflammatory Lung Diseases Using Advanced Drug Delivery Systems
  • 1. Chronic respiratory diseases: An introduction and need for novel drug delivery approaches2. Drug delivery of respiratory medicines in practice3. Advanced drug delivery systems for respiratory diseases4. Novel drug delivery systems and significance in respiratory diseases5. Use of biologics in the treatment of asthma, COPD, ACOS, and idiopathic pulmonary fibrosis6. Targeting biofilms in chronic respiratory infections using drug delivery systems7. Absorption enhancement of macromolecule administered intrapulmonary8. In silico analysis of drug delivery in respiratory disease9. Concepts of nanotechnology in nanomedicine: From discovery to applications10. Advancement in translational respiratory research using nanotechnology 11. Nanoparticle-based macromolecule drug delivery to lungs12. Formulation and role of polymeric and inorganic nanoparticles in respiratory diseases13. Inhalable hybrid nanocarriers for respiratory disorders14. Functionalized nanoparticles in pulmonary disease diagnosis15. Drug delivery system in pulmonary disease: Role of microparticles16. Microparticulate drug delivery systems for targeting respiratory diseases17. Porous particulate platforms for enhanced pulmonary delivery of bioactives18. Liposomes in the treatment of chronic respiratory conditions19. Theranostic drug delivery systems for targeted therapy of lung diseases20. Targeted polymeric miceller systems for respiratory diseases21. Hydrogels for pulmonary drug delivery22. Mucoadhesive drug delivery systems in respiratory diseases23. Targeting lung cancer using advanced drug delivery systems24. Plant-based drug delivery systems in respiratory diseases25. Role of essential oils in respiratory diseases through advanced and nanodrug delivery systems26. Pharmacokinetics and pharmacodynamics of the advanced drug delivery systems